NCT05117970View on ClinicalTrials.gov

Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using Electrocardiograms

NACompletedINTERVENTIONAL
Enrollment

13,631

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

December 31, 2023

Conditions
Left Ventricular Systolic Dysfunction (Disorder)
Interventions
OTHER

AI-enabled ECG-based Screening Tool

Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative.The system will send a message to corresponding physicians if positive finding.

Trial Locations (1)

114

National Defense Medical Center, Taipei

All Listed Sponsors
lead

National Defense Medical Center, Taiwan

OTHER

NCT05117970 - Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using Electrocardiograms | Biotech Hunter | Biotech Hunter